Facebook
Twitter
LinkedIn
ForwardHead and Neck Cancer - Prevention and Management of Radiation Therapy Toxicity (PRO 09)
Head and neck cancer patients experience severe acute and late toxicity from radiation therapy. This activity explores ways to prevent, mitigate and treat toxicities from treatment. The first presenter discusses dosimetric and planning parameters to reduce toxicity. The second speaker reviews practical management considerations for management of patients and acute side effects during treatment. The third topic is management of late side effects from treatment.
Target Audience
This activity is designed to meet the interests of medical oncologists, radiation oncologists, nurses, radiation therapists, SLP's and dietitians.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Explain planning techniques to prevent treatment related side effects from head and neck cancer radiation.
- Describe management techniques to treat acute and late side effects from radiation to the head and neck.
- Virginia M. Diavolitsis, MD, is employed by Riverside Radiation Oncology Inc.
- Shauna Rosalie Campbell, DO, is employed by Cleveland Clinic.
- Carryn M. Anderson, MD, is employed University of Iowa Hospitals and Clinics.
- Darrion L. Mitchell, MD, PhD, is employed by James Cancer Hospital, The Ohio State University.
All relevant financial relationships have been mitigated.
The person(s) above served as the developer(s) of this activity. Additionally, the Annual Meeting Steering Committee had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 1.25 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.